X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Facilities & Operation

NHS Lays Long COVID Action Plan For Many With Chronic Signs

Content Team by Content Team
30th July 2022
in Facilities & Operation, News
NHS Lays Long COVID Action Plan For Many With Chronic Signs

Instead of having patients return to their GP office for a variety of tests, lengthy COVID specialist clinics will now be able to refer patients to nearby one-stop shops and mobile clinics. The modified long-COVID plan, which is supported by an incremental £90 million investment, intends to have all patients have an initial examination within six weeks in order to ensure prompt diagnosis and treatment.

According to the most recent ONS estimates, 1.6 million people in England have continuous COVID symptoms that have lasted for more than four weeks, and one in five of them feels it has a considerable impact on their everyday lives. The plan, which was created with the assistance of patients, doctors, and other partners from throughout the health and care system, demonstrates the NHS has made great strides toward fulfilling the 10 promises it set for long-term COVID services just over a year ago.

In order to assist GP teams in treating the illness, this involves establishing a national network of 90 specialised long COVID clinics, 14 centres for children and young adults, and funding for training and advice. In Mid and South Essex, a community outreach van is already seeing patients with suspected long-term COVID symptoms for regular meetings and walk-ins before recommending them for additional evaluations if necessary.

The mobile service provides a variety of examinations, comprising electrocardiography, blood pressure monitoring, heart rate monitoring, oxygen saturation monitoring, spirometry, and other testing for dyspnea.

Long COVID may be terrible for those who have it, and although they continue to learn more about this new ailment, it’s essential that people know that they are not alone and that the NHS is available to them, according to GP and chair of the NHS long COVID taskforce, Dr. Kiren Collison.

In just under 2 years, the NHS has committed £224 million to supporting individuals who have suffered from COVID’s long-term impacts. This money was used to establish specialist clinics, child centres, online rehabilitation platforms, and training programmes for GP teams. The strategy announced today builds on this internationally renowned care to ensure that assistance is there for all who need it and that patients seeking professional assistance may receive treatment in a quicker and more practical way.

The NHS has established specialised long COVID clinics across the nation for those struggling with the more complex and severe symptoms. Many people who are experiencing long-term symptoms will fully recover with intervention from their community healthcare or GP team.

In addition to physical, cognitive, and psychological examinations and management, long COVID clinics can also make referrals for additional rehab, therapy, and other assistance.

Lizzie Burr, 62, of Warwick, was referred to a nearby long-term COVID clinic. She explained that she contracted COVID in early 2020 and at first treated her symptoms at home in the hope that they would go away. However, more than a month later, she was still extremely ill, and her condition did not appear to be getting any better. She was experiencing nausea, a loss of appetite, trouble sleeping, and extreme exhaustion, which significantly restricted her mobility.

Her GP recommended that she visit the extended COVID clinic in Stratford, and after a preliminary evaluation, she received specialised assistance from a respiratory physiotherapist to help with her breathing as well as a dietitian who has assisted her with food and exercise. She cannot say enough good things about the lengthy COVID clinic, which has been a lifeline for her and helped her both physically and mentally, even though she is still in the process of recovering. She would advise anyone who is concerned about extended COVID to get assistance and contact their GP staff.

The health of people of all ages can be negatively impacted by long-term COVID, according to health minister James Morris. Such new measures will make sure people with this terrible ailment get the assistance they need more swiftly and nearby.

The strategy demonstrates the remarkable advances the NHS has achieved in offering additional care to patients in conjunction with the globally recognised immunisation campaign, which has administered more than 150 million vaccinations to protect individuals against the virus. Over 45,000 individuals with severe or complicated symptoms have contacted a post-COVID service specialist in the past year.

On the NHS Your COVID Recovery page, anyone with questions or concerns regarding lingering symptoms after COVID-19 can find guidance and information. This online resource offers professional guidance on what people may do as they recover from illness; what to watch out for if the condition persists; and where to find support for persistent symptoms.

Over 10 million individuals have used the online programme since it began, and it is now available in 17 languages, including Arabic, Chinese, Gujarati, Hindi, Polish, Ukrainian, and Urdu. They should get in touch with their GP team if they have any unanswered questions or are not improving as anticipated.

Previous Post

Pfizer Has Long-Term Plans For Paxlovid, Comirnaty, COVID-19

Next Post

Automated Dried Spot Sampling and Analysis System Redefines Workflow

Related Posts

SCHOTT Pharma Invests
News

SCHOTT Pharma Invests EUR 100 Million in RTU Cartridges

9th June 2025
Stringent Policy around COVID Vaccines Laid by FDA
FDA Approvals

Stringent Policy around COVID Vaccines Laid by FDA

29th May 2025
Pharmaceutical-Chemicals Market Booms with Rising API Demand
Asia

Pharmaceutical Chemicals Market Booms with Rising API Demand

28th May 2025
Drugmakers Asked to Strictly Follow the US Pricing Reforms
Manufacturing

Drugmakers Asked to Strictly Follow the US Pricing Reforms

28th May 2025
DHL Supply Chain
News

DHL Supply Chain comes up with New Pharma Hub in Singapore

19th April 2025
Healthcare Packaging
Asia

Amcor Healthcare Packaging Expansion in Asia Pacific

16th April 2025
Next Post
Automated Dried Spot Sampling and Analysis System Redefines Workflow

Automated Dried Spot Sampling and Analysis System Redefines Workflow

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In